SELLAS Life Sciences Group, Inc. SLS Return on assets
Return on assets at other companies
Other financials
Where this comes from
Calculated from SELLAS Life Sciences Group, Inc.’s reported figures.
Based on trailing twelve months.
The official record: SELLAS Life Sciences Group, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about SELLAS Life Sciences Group, Inc.'s return on assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is SELLAS Life Sciences Group, Inc.'s return on assets?
- SELLAS Life Sciences Group, Inc. (SLS) reported return on assets of -39.5% in Q1 2026.
- How has SELLAS Life Sciences Group, Inc.'s return on assets changed year-over-year?
- SELLAS Life Sciences Group, Inc.'s return on assets increased by 56.8% year-over-year, from -91.4% to -39.5%.
- What is the long-term trend for SELLAS Life Sciences Group, Inc.'s return on assets?
- Over 5 years (2020 to 2025), SELLAS Life Sciences Group, Inc.'s return on assets has grown at a 0.5% compound annual growth rate (CAGR), from -53.5% to -54.9%.
- What does return on assets mean?
- Trailing-twelve-month net income divided by average total assets. Measures how efficiently the asset base generates profit, independent of how those assets are financed. Computed as net income over average total assets — note this is OpenCapital's standard definition and may differ from data vendors that use alternative numerators.